Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 30:2022:6973151.
doi: 10.1155/2022/6973151. eCollection 2022.

An Overview of Systematic Reviews on the Effectiveness of Wenxin Keli in the Treatment of Atrial Fibrillation

Yuanping Wang  1 , Yuntao Liu  2 , Xia Yan  2 , Dawei Wang  1
Affiliations

An Overview of Systematic Reviews on the Effectiveness of Wenxin Keli in the Treatment of Atrial Fibrillation

Yuanping Wang et al. Evid Based Complement Alternat Med. .

Abstract

Background: Atrial fibrillation is one of the most common cardiac arrhythmias. Wenxin Keli (WXKL) is a Chinese herbal extract widely used in China to treat patients with atrial fibrillation. This study aimed to outline and summarize the current evidence of systematic reviews (SRs)/meta-analyses (MAs) investigating the clinical efficacy of WXKL in atrial fibrillation.

Methods: From inception to December 2021, 6 electronic databases in English and Chinese were searched for potential SRs/MAs. The GRADE (Grading of Recommendations Assessment, Development, and Evaluation), PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) checklist, and AMSTAR-2 (Assessing the Methodological Quality of Systematic Reviews-2) were used to evaluate the quality of the evidence, reporting, and methodology of SRs/MAs regarding WXKL for the treatment of atrial fibrillation.

Results: A total of 8 SRs/MAs were included in the present study. The results of AMSTAR-2 and PRISMA were unsatisfactory for the main insufficiency founded in registration and protocol, search strategy, excluded study statement, evidence certainty assessment, and funding and conflict of interest information. All the included SRs/MAs were assessed as very low in methodological quality. Moreover, 23 outcomes were evaluated by GRADE for the certainty of evidence, and 2 outcomes were assessed as moderate, while 15 were low and 6 were very low. Risk of bias and publication bias contributed to the downgrading.

Conclusion: WXKL may be clinically efficacious and safe for the treatment of atrial fibrillation. This finding, however, should be regarded with caution because of the low level of evidence and methodological qualities of the involved SRs/MAs. More standardized, rigorous, and comprehensive SRs/MAs and randomized control trials are needed to provide strong evidence to reach more convincing conclusions.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.

Figures

Figure 1
Figure 1
.The flowchart of the screening process.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Chugh S. S., Havmoeller R., Narayanan K., et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation . 2014;129(8):837–847. doi: 10.1161/circulationaha.113.005119. - DOI - PMC - PubMed
    1. Morillo C. A., Banerjee A., Perel P., Wood D., Jouven X. Atrial fibrillation: the current epidemic. Journal of Geriatric Cardiology . 2017;14(3):195–203. doi: 10.11909/j.issn.1671-5411.2017.03.011. - DOI - PMC - PubMed
    1. Schnabel R. B., Yin X., Gona P., et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the framingham heart study: a cohort study. The Lancet . 2015;386(9989):154–162. doi: 10.1016/s0140-6736(14)61774-8. - DOI - PMC - PubMed
    1. Ehrlich J. R., Nattel S., Hohnloser S. H. Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets. Journal of Cardiovascular Electrophysiology . 2002;13(4):399–405. doi: 10.1046/j.1540-8167.2002.00399.x. - DOI - PubMed
    1. Zhang J., Johnsen S. P., Guo Y., Lip G. Y. H. Epidemiology of atrial fibrillation: geographic/ecological risk factors, age, sex, genetics. Cardiac Electrophysiology Clinics . 2021;13(1):1–23. doi: 10.1016/j.ccep.2020.10.010. - DOI - PubMed

LinkOut - more resources